PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Griciuc, A. ; Aron, L.* ; Ueffing, M.

ER stress in retinal degeneration: A target for rational therapy?

Trends Mol. Med. 17, 442-451 (2011)
DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Mutations that cause rhodopsin misfolding and retention within the endoplasmic reticulum (ER) are a prominent cause of retinitis pigmentosa. Here, we discuss the hypothesis that the failure of photoreceptor neurons to adapt to the stress caused by rhodopsin accumulation in the ER leads to a global collapse of homeostasis and to retinal degeneration. We review the molecular mechanisms underlying the activity of local ER conformational sensors and stress-relaying modules and consider how ER-derived stress signals are amplified and implemented to impact on downstream processes, including rhodopsin clearance and cell fate control. The emerging view is that alterations to the systems responsible for the detection, transduction and implementation of ER stress might be used therapeutically to treat retinitis pigmentosa.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
10.308
2.653
23
46
Tags
PROT-CF
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter endoplasmic-reticulum stress; unfolded protein response; dominant retinitis-pigmentosa; ubiquitin-proteasome system; cell-death; rhodopsin maturation; mutant rhodopsin; mouse model; in-vivo; degradation
Sprache englisch
Veröffentlichungsjahr 2011
HGF-Berichtsjahr 2011
ISSN (print) / ISBN 1471-4914
e-ISSN 1471-499X
Zeitschrift Trends in Molecular Medicine
Quellenangaben Band: 17, Heft: 8, Seiten: 442-451 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort Oxford, UK
Begutachtungsstatus Peer reviewed
Institut(e) CF Metabolomics & Proteomics (CF-MPC)
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Enabling and Novel Technologies
PSP-Element(e) G-505700-001
PubMed ID 21620769
DOI 10.1016/j.molmed.2011.04.002
Scopus ID 80955178939
Erfassungsdatum 2011-11-07
[➜Korrektur melden]